Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Recent advances in artificial intelligence systemsSMi reports: Hear from Gisbert Scnieder, Professor, Chair for Computer-Assisted Drug Design, ETH Zurich at SMi's Drug Discovery conference in March
By: SMI Hear more from Gisbert Scnieder at SMi's Drug Discovery conference taking place in London on 21st and 22nd March 2018. Mr Scnieder will discuss "Artificially Intelligent Drug Design": De Novo Compound Design in Silico; Target Prediction and Off-Target Profiling; Automating Drug Discovery by Machine Learning. Exscientia, BenevolentAI and AstraZeneca will also be presenting on Artificial Intelligence in Drug Discovery. SMi are additionally hosting two pre-conference workshops on Tuesday 20th March which will be lead by Axol Bioscience and AstraZeneca. Get to understand the revolutionary biological technique of creating induced pluripotent stem cells (iPSC) from any source material. Learn about sourcing of healthy and disease cells from patient material, including possible ethical and consensual pitfalls. Learn a historical perspective of reprogramming technology and the fundamentals of turning cells into the iPSC state. Learn how to use CRISPR/CAS9 to create disease models in iPSCs. Learn from AstraZeneca's UK Lead for Genome Editing / CRISPR on how genome editing has revolutionised drug development and so much more! For more details about the conference and registration information, visit www.drug-discovery.co.uk/ Drug Discovery 21st – 22nd March 2018 Copthorne Tara Hotel, London, UK www.drug-discovery.co.uk/ ---end --- Contact Information: For sponsorship and exhibition queries please contact Alia Malick at amalick@smi- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|